Insider Trading & Ownership - BRYCE RICHARD PAUL

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BRYCE RICHARD PAUL
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-04-05
Sale
2021-04-06
5:54 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
426$9.8029$4,176121,662
(Direct)
View
2021-03-02
Sale
2021-03-04
4:40 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
422$10.15$4,283122,088
(Direct)
View
2021-02-02
Sale
2021-02-03
7:39 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
415$12.23$5,07669,664
(Direct)
View
2021-01-04
Sale
2021-01-06
6:36 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
6,548$10.23$67,01670,079
(Direct)
View
2020-12-02
Sale
2020-12-04
4:34 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
92$11.65$1,07276,627
(Direct)
View
2020-11-02
Sale
2020-11-03
7:28 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
97$7.81$75876,719
(Direct)
View
2020-10-02
Sale
2020-10-05
5:25 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
91$10.14$92376,816
(Direct)
View
2020-09-02
Sale
2020-09-03
5:27 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
90$9.77$87976,907
(Direct)
View
2020-08-03
Sale
2020-08-05
4:35 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
86$10.8$92976,997
(Direct)
View
2020-07-02
Sale
2020-07-06
8:02 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
660$10.67$7,04077,083
(Direct)
View
2020-06-02
Sale
2020-06-03
5:26 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
89$10.66$94977,743
(Direct)
View
2020-05-04
Sale
2020-05-06
4:55 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
89$9.6201$85677,832
(Direct)
View
2020-04-02
Sale
2020-04-03
4:42 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
91$7.3701$67177,921
(Direct)
View
2020-03-02
Sale
2020-03-03
4:41 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
96$10.02$96278,012
(Direct)
View
2020-02-03
Sale
2020-02-04
5:41 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
105$8.015$84234,834
(Direct)
View
2020-01-02
Sale
2020-01-03
4:31 pm
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
1,516$8.3999$12,73434,939
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-30
Option Award
2023-12-04
5:55 pm
N/A
2033-11-30
enGene Holdings Inc.ENGNBRYCE RICHARD PAUL
Chief Medical Officer
153,000$0153,000
(Direct)
View
2023-02-15
Option Award
2023-02-17
6:21 pm
N/A
2033-02-15
Rain Oncology Inc.RAINBRYCE RICHARD PAUL
Chief Medical Officer
110,000$0110,000
(Direct)
View
2022-01-07
Option Award
2022-02-04
4:40 pm
N/A
2032-01-07
Rain Therapeutics Inc.RAINBRYCE RICHARD PAUL
Chief Medical Officer
53,064$053,064
(Direct)
View

Ownership
2021-04-22
7:15 pm
N/A
2031-04-13
Rain Therapeutics Inc.RAINBRYCE RICHARD PAUL
Chief Medical Officer
0$0194,462
(Direct)
View
2021-02-17
Option Award
2021-02-19
6:22 pm
N/A
2031-02-16
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
127,187$0196,851
(Direct)
View
2020-02-11
Option Award
2020-02-13
7:59 pm
N/A
2030-02-10
PUMA BIOTECHNOLOGY INC.PBYIBRYCE RICHARD PAUL
SEE REMARKS
98,116$0132,950
(Direct)
View